nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—Cisplatin—germ cell cancer	0.217	0.389	CbGbCtD
Mesalazine—PTGS1—Ifosfamide—germ cell cancer	0.13	0.233	CbGbCtD
Mesalazine—PTGS2—Cisplatin—germ cell cancer	0.0749	0.134	CbGbCtD
Mesalazine—PTGS2—Etoposide—germ cell cancer	0.0736	0.132	CbGbCtD
Mesalazine—PTGS1—Etoposide—germ cell cancer	0.0622	0.111	CbGbCtD
Mesalazine—PPARG—dermis—germ cell cancer	0.00734	0.0743	CbGeAlD
Mesalazine—Dopamine—POU5F1—germ cell cancer	0.00573	0.815	CrCbGaD
Mesalazine—PPARG—Teniposide—Etoposide—germ cell cancer	0.00382	1	CbGdCrCtD
Mesalazine—PPARG—appendage—germ cell cancer	0.00371	0.0376	CbGeAlD
Mesalazine—MPO—endothelium—germ cell cancer	0.00253	0.0256	CbGeAlD
Mesalazine—MPO—blood vessel—germ cell cancer	0.00233	0.0236	CbGeAlD
Mesalazine—CHUK—skin of body—germ cell cancer	0.00226	0.0229	CbGeAlD
Mesalazine—PPARG—endothelium—germ cell cancer	0.00224	0.0227	CbGeAlD
Mesalazine—PPARG—blood vessel—germ cell cancer	0.00207	0.0209	CbGeAlD
Mesalazine—IKBKB—embryo—germ cell cancer	0.00198	0.0201	CbGeAlD
Mesalazine—PTGS2—appendage—germ cell cancer	0.0019	0.0192	CbGeAlD
Mesalazine—CHUK—adrenal gland—germ cell cancer	0.00172	0.0175	CbGeAlD
Mesalazine—IKBKB—telencephalon—germ cell cancer	0.00161	0.0163	CbGeAlD
Mesalazine—CHUK—female gonad—germ cell cancer	0.00161	0.0163	CbGeAlD
Mesalazine—PTGS2—skin epidermis—germ cell cancer	0.00158	0.016	CbGeAlD
Mesalazine—IKBKB—skin of body—germ cell cancer	0.00154	0.0156	CbGeAlD
Mesalazine—IKBKB—decidua—germ cell cancer	0.00153	0.0155	CbGeAlD
Mesalazine—CHUK—endocrine gland—germ cell cancer	0.0015	0.0151	CbGeAlD
Mesalazine—PPARG—neck—germ cell cancer	0.00148	0.015	CbGeAlD
Mesalazine—CHUK—head—germ cell cancer	0.00148	0.0149	CbGeAlD
Mesalazine—CHUK—testis—germ cell cancer	0.00143	0.0144	CbGeAlD
Mesalazine—PTGS1—ganglion—germ cell cancer	0.00139	0.0141	CbGeAlD
Mesalazine—IKBKB—gonad—germ cell cancer	0.00134	0.0136	CbGeAlD
Mesalazine—IKBKB—uterus—germ cell cancer	0.00134	0.0135	CbGeAlD
Mesalazine—CHUK—cerebellum—germ cell cancer	0.00132	0.0133	CbGeAlD
Mesalazine—IKBKB—pituitary gland—germ cell cancer	0.00131	0.0133	CbGeAlD
Mesalazine—Dopamine—SLC22A3—germ cell cancer	0.0013	0.185	CrCbGaD
Mesalazine—ALOX5—decidua—germ cell cancer	0.00127	0.0128	CbGeAlD
Mesalazine—PPARG—embryo—germ cell cancer	0.00123	0.0125	CbGeAlD
Mesalazine—PTGS1—endothelium—germ cell cancer	0.0012	0.0121	CbGeAlD
Mesalazine—IKBKB—adrenal gland—germ cell cancer	0.00117	0.0119	CbGeAlD
Mesalazine—PTGS2—endothelium—germ cell cancer	0.00115	0.0116	CbGeAlD
Mesalazine—PTGS1—blood vessel—germ cell cancer	0.0011	0.0112	CbGeAlD
Mesalazine—IKBKB—female gonad—germ cell cancer	0.00109	0.0111	CbGeAlD
Mesalazine—MPO—skin of body—germ cell cancer	0.00108	0.0109	CbGeAlD
Mesalazine—CHUK—brain—germ cell cancer	0.00107	0.0108	CbGeAlD
Mesalazine—PTGS2—blood vessel—germ cell cancer	0.00106	0.0107	CbGeAlD
Mesalazine—CHUK—lymph node—germ cell cancer	0.00103	0.0105	CbGeAlD
Mesalazine—IKBKB—endocrine gland—germ cell cancer	0.00102	0.0103	CbGeAlD
Mesalazine—IKBKB—head—germ cell cancer	0.001	0.0102	CbGeAlD
Mesalazine—ALOX5—adrenal gland—germ cell cancer	0.000971	0.00983	CbGeAlD
Mesalazine—IKBKB—testis—germ cell cancer	0.000969	0.00981	CbGeAlD
Mesalazine—PPARG—skin of body—germ cell cancer	0.000957	0.00969	CbGeAlD
Mesalazine—PPARG—decidua—germ cell cancer	0.00095	0.00962	CbGeAlD
Mesalazine—ALOX5—bone marrow—germ cell cancer	0.00094	0.00951	CbGeAlD
Mesalazine—MPO—pituitary gland—germ cell cancer	0.00092	0.00931	CbGeAlD
Mesalazine—ALOX5—female gonad—germ cell cancer	0.000906	0.00917	CbGeAlD
Mesalazine—IKBKB—cerebellum—germ cell cancer	0.000895	0.00906	CbGeAlD
Mesalazine—ALOX5—endocrine gland—germ cell cancer	0.000842	0.00853	CbGeAlD
Mesalazine—ALOX5—head—germ cell cancer	0.000832	0.00842	CbGeAlD
Mesalazine—PPARG—uterus—germ cell cancer	0.000831	0.00842	CbGeAlD
Mesalazine—MPO—adrenal gland—germ cell cancer	0.000822	0.00832	CbGeAlD
Mesalazine—ALOX5—testis—germ cell cancer	0.000803	0.00813	CbGeAlD
Mesalazine—MPO—bone marrow—germ cell cancer	0.000795	0.00805	CbGeAlD
Mesalazine—MPO—spinal cord—germ cell cancer	0.000792	0.00802	CbGeAlD
Mesalazine—ALOX5—cerebellum—germ cell cancer	0.000742	0.00751	CbGeAlD
Mesalazine—PPARG—adrenal gland—germ cell cancer	0.000729	0.00738	CbGeAlD
Mesalazine—IKBKB—brain—germ cell cancer	0.000727	0.00736	CbGeAlD
Mesalazine—MPO—endocrine gland—germ cell cancer	0.000713	0.00722	CbGeAlD
Mesalazine—PPARG—bone marrow—germ cell cancer	0.000706	0.00714	CbGeAlD
Mesalazine—MPO—head—germ cell cancer	0.000704	0.00712	CbGeAlD
Mesalazine—IKBKB—lymph node—germ cell cancer	0.000703	0.00711	CbGeAlD
Mesalazine—PPARG—female gonad—germ cell cancer	0.00068	0.00688	CbGeAlD
Mesalazine—MPO—testis—germ cell cancer	0.00068	0.00688	CbGeAlD
Mesalazine—PTGS2—trigeminal ganglion—germ cell cancer	0.000652	0.00661	CbGeAlD
Mesalazine—PPARG—endocrine gland—germ cell cancer	0.000632	0.0064	CbGeAlD
Mesalazine—PTGS2—embryo—germ cell cancer	0.00063	0.00638	CbGeAlD
Mesalazine—PPARG—head—germ cell cancer	0.000624	0.00632	CbGeAlD
Mesalazine—PPARG—testis—germ cell cancer	0.000603	0.00611	CbGeAlD
Mesalazine—ALOX5—brain—germ cell cancer	0.000603	0.0061	CbGeAlD
Mesalazine—ALOX5—lymph node—germ cell cancer	0.000582	0.0059	CbGeAlD
Mesalazine—PTGS1—telencephalon—germ cell cancer	0.000536	0.00543	CbGeAlD
Mesalazine—PTGS2—telencephalon—germ cell cancer	0.000512	0.00519	CbGeAlD
Mesalazine—PTGS1—skin of body—germ cell cancer	0.000512	0.00518	CbGeAlD
Mesalazine—MPO—brain—germ cell cancer	0.00051	0.00516	CbGeAlD
Mesalazine—MPO—lymph node—germ cell cancer	0.000493	0.00499	CbGeAlD
Mesalazine—PTGS2—skin of body—germ cell cancer	0.000489	0.00495	CbGeAlD
Mesalazine—PPARG—brain—germ cell cancer	0.000452	0.00458	CbGeAlD
Mesalazine—PTGS1—uterus—germ cell cancer	0.000444	0.0045	CbGeAlD
Mesalazine—PPARG—lymph node—germ cell cancer	0.000437	0.00443	CbGeAlD
Mesalazine—PTGS1—pituitary gland—germ cell cancer	0.000436	0.00442	CbGeAlD
Mesalazine—PTGS2—uterus—germ cell cancer	0.000425	0.0043	CbGeAlD
Mesalazine—PTGS2—pituitary gland—germ cell cancer	0.000417	0.00422	CbGeAlD
Mesalazine—PTGS2—medulla oblongata—germ cell cancer	0.000403	0.00408	CbGeAlD
Mesalazine—PTGS1—adrenal gland—germ cell cancer	0.00039	0.00395	CbGeAlD
Mesalazine—PTGS1—spinal cord—germ cell cancer	0.000376	0.0038	CbGeAlD
Mesalazine—PTGS2—adrenal gland—germ cell cancer	0.000373	0.00377	CbGeAlD
Mesalazine—PTGS2—midbrain—germ cell cancer	0.000368	0.00373	CbGeAlD
Mesalazine—PTGS1—female gonad—germ cell cancer	0.000364	0.00368	CbGeAlD
Mesalazine—PTGS2—bone marrow—germ cell cancer	0.000361	0.00365	CbGeAlD
Mesalazine—PTGS2—spinal cord—germ cell cancer	0.000359	0.00363	CbGeAlD
Mesalazine—PTGS2—female gonad—germ cell cancer	0.000347	0.00352	CbGeAlD
Mesalazine—PTGS1—endocrine gland—germ cell cancer	0.000338	0.00342	CbGeAlD
Mesalazine—PTGS1—head—germ cell cancer	0.000334	0.00338	CbGeAlD
Mesalazine—PTGS2—endocrine gland—germ cell cancer	0.000323	0.00327	CbGeAlD
Mesalazine—PTGS1—testis—germ cell cancer	0.000322	0.00326	CbGeAlD
Mesalazine—PTGS2—head—germ cell cancer	0.000319	0.00323	CbGeAlD
Mesalazine—PTGS2—cerebellum—germ cell cancer	0.000285	0.00288	CbGeAlD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—FGF4—germ cell cancer	0.000257	0.00373	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—KLF4—germ cell cancer	0.000256	0.00373	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—KIT—germ cell cancer	0.000255	0.0037	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—KITLG—germ cell cancer	0.000251	0.00365	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—FGF4—germ cell cancer	0.000251	0.00365	CbGpPWpGaD
Mesalazine—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—MYC—germ cell cancer	0.00025	0.00364	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—KITLG—germ cell cancer	0.00025	0.00364	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—KITLG—germ cell cancer	0.00025	0.00363	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—KIT—germ cell cancer	0.000248	0.00361	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—KITLG—germ cell cancer	0.000248	0.00361	CbGpPWpGaD
Mesalazine—PPARG—Wnt Signaling Pathway Netpath—MYC—germ cell cancer	0.000248	0.0036	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—KITLG—germ cell cancer	0.000247	0.00359	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—KIT—germ cell cancer	0.000247	0.00359	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KITLG—germ cell cancer	0.000244	0.00354	CbGpPWpGaD
Mesalazine—PTGS1—brain—germ cell cancer	0.000242	0.00245	CbGeAlD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—germ cell cancer	0.000241	0.0035	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—FGF4—germ cell cancer	0.000237	0.00345	CbGpPWpGaD
Mesalazine—PTGS1—lymph node—germ cell cancer	0.000234	0.00237	CbGeAlD
Mesalazine—CHUK—Signaling by FGFR in disease—KITLG—germ cell cancer	0.000232	0.00338	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KITLG—germ cell cancer	0.000232	0.00338	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—KITLG—germ cell cancer	0.000232	0.00338	CbGpPWpGaD
Mesalazine—PTGS2—brain—germ cell cancer	0.000231	0.00234	CbGeAlD
Mesalazine—CHUK—Signaling by EGFR—KITLG—germ cell cancer	0.00023	0.00335	CbGpPWpGaD
Mesalazine—CHUK—PDGF Pathway—HRAS—germ cell cancer	0.00023	0.00334	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—KITLG—germ cell cancer	0.000228	0.00332	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—KITLG—germ cell cancer	0.000227	0.00331	CbGpPWpGaD
Mesalazine—MPO—C-MYB transcription factor network—HRAS—germ cell cancer	0.000227	0.0033	CbGpPWpGaD
Mesalazine—PTGS2—lymph node—germ cell cancer	0.000223	0.00226	CbGeAlD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KITLG—germ cell cancer	0.000221	0.00321	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—AVP—germ cell cancer	0.000219	0.00318	CbGpPWpGaD
Mesalazine—IKBKB—GMCSF-mediated signaling events—HRAS—germ cell cancer	0.000217	0.00316	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—KITLG—germ cell cancer	0.000215	0.00313	CbGpPWpGaD
Mesalazine—Anorexia—Dactinomycin—germ cell cancer	0.000214	0.000811	CcSEcCtD
Mesalazine—Eye disorder—Etoposide—germ cell cancer	0.000214	0.00081	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000213	0.000807	CcSEcCtD
Mesalazine—Cardiac disorder—Etoposide—germ cell cancer	0.000212	0.000804	CcSEcCtD
Mesalazine—Discomfort—Ifosfamide—germ cell cancer	0.000212	0.000803	CcSEcCtD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KITLG—germ cell cancer	0.000211	0.00307	CbGpPWpGaD
Mesalazine—Hypersensitivity—Vinblastine—germ cell cancer	0.00021	0.000795	CcSEcCtD
Mesalazine—Decreased appetite—Bleomycin—germ cell cancer	0.000209	0.000793	CcSEcCtD
Mesalazine—Muscle spasms—Cisplatin—germ cell cancer	0.000209	0.000791	CcSEcCtD
Mesalazine—CHUK—Interleukin-11 Signaling Pathway—HRAS—germ cell cancer	0.000209	0.00304	CbGpPWpGaD
Mesalazine—Angiopathy—Etoposide—germ cell cancer	0.000207	0.000786	CcSEcCtD
Mesalazine—Confusional state—Ifosfamide—germ cell cancer	0.000207	0.000786	CcSEcCtD
Mesalazine—CHUK—Signaling by SCF-KIT—FGFR3—germ cell cancer	0.000207	0.00301	CbGpPWpGaD
Mesalazine—Immune system disorder—Etoposide—germ cell cancer	0.000207	0.000783	CcSEcCtD
Mesalazine—Mediastinal disorder—Etoposide—germ cell cancer	0.000206	0.000781	CcSEcCtD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	0.000206	0.003	CbGpPWpGaD
Mesalazine—Pain—Bleomycin—germ cell cancer	0.000206	0.00078	CcSEcCtD
Mesalazine—Oedema—Ifosfamide—germ cell cancer	0.000206	0.000779	CcSEcCtD
Mesalazine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000206	0.000779	CcSEcCtD
Mesalazine—Chills—Etoposide—germ cell cancer	0.000205	0.000777	CcSEcCtD
Mesalazine—Vision blurred—Cisplatin—germ cell cancer	0.000205	0.000776	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000205	0.000775	CcSEcCtD
Mesalazine—Asthenia—Vinblastine—germ cell cancer	0.000204	0.000775	CcSEcCtD
Mesalazine—Infection—Ifosfamide—germ cell cancer	0.000204	0.000774	CcSEcCtD
Mesalazine—Tremor—Cisplatin—germ cell cancer	0.000204	0.000771	CcSEcCtD
Mesalazine—Alopecia—Etoposide—germ cell cancer	0.000202	0.000766	CcSEcCtD
Mesalazine—Lethargy—Methotrexate—germ cell cancer	0.000202	0.000765	CcSEcCtD
Mesalazine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000202	0.000764	CcSEcCtD
Mesalazine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000202	0.000764	CcSEcCtD
Mesalazine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000201	0.000763	CcSEcCtD
Mesalazine—Anaemia—Cisplatin—germ cell cancer	0.000201	0.000761	CcSEcCtD
Mesalazine—Skin disorder—Ifosfamide—germ cell cancer	0.0002	0.000757	CcSEcCtD
Mesalazine—PPARG—Gene Expression—NR0B1—germ cell cancer	0.0002	0.0029	CbGpPWpGaD
Mesalazine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000199	0.000753	CcSEcCtD
Mesalazine—Feeling abnormal—Bleomycin—germ cell cancer	0.000198	0.000751	CcSEcCtD
Mesalazine—CHUK—Downstream signaling of activated FGFR—FGFR3—germ cell cancer	0.000198	0.00288	CbGpPWpGaD
Mesalazine—Osteoarthritis—Methotrexate—germ cell cancer	0.000198	0.00075	CcSEcCtD
Mesalazine—CHUK—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	0.000197	0.00287	CbGpPWpGaD
Mesalazine—Anorexia—Ifosfamide—germ cell cancer	0.000196	0.000743	CcSEcCtD
Mesalazine—Malaise—Cisplatin—germ cell cancer	0.000196	0.000742	CcSEcCtD
Mesalazine—Decreased appetite—Dactinomycin—germ cell cancer	0.000195	0.000739	CcSEcCtD
Mesalazine—CHUK—Signaling by ERBB4—FGFR3—germ cell cancer	0.000195	0.00284	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—KITLG—germ cell cancer	0.000195	0.00284	CbGpPWpGaD
Mesalazine—Diarrhoea—Vinblastine—germ cell cancer	0.000195	0.000739	CcSEcCtD
Mesalazine—Dysgeusia—Etoposide—germ cell cancer	0.000195	0.000739	CcSEcCtD
Mesalazine—Leukopenia—Cisplatin—germ cell cancer	0.000195	0.000737	CcSEcCtD
Mesalazine—Fatigue—Dactinomycin—germ cell cancer	0.000194	0.000733	CcSEcCtD
Mesalazine—CHUK—Signaling by NGF—FGF4—germ cell cancer	0.000193	0.0028	CbGpPWpGaD
Mesalazine—Back pain—Etoposide—germ cell cancer	0.000193	0.000729	CcSEcCtD
Mesalazine—Hypotension—Ifosfamide—germ cell cancer	0.000192	0.000728	CcSEcCtD
Mesalazine—Pain—Dactinomycin—germ cell cancer	0.000192	0.000727	CcSEcCtD
Mesalazine—Muscle spasms—Etoposide—germ cell cancer	0.000191	0.000725	CcSEcCtD
Mesalazine—Urticaria—Bleomycin—germ cell cancer	0.000191	0.000724	CcSEcCtD
Mesalazine—Body temperature increased—Bleomycin—germ cell cancer	0.00019	0.000721	CcSEcCtD
Mesalazine—CHUK—Signaling by SCF-KIT—KIT—germ cell cancer	0.00019	0.00277	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	0.00019	0.00276	CbGpPWpGaD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—HRAS—germ cell cancer	0.000189	0.00275	CbGpPWpGaD
Mesalazine—Dizziness—Vinblastine—germ cell cancer	0.000188	0.000714	CcSEcCtD
Mesalazine—Mood swings—Methotrexate—germ cell cancer	0.000188	0.000711	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000187	0.00071	CcSEcCtD
Mesalazine—CHUK—Downstream signal transduction—FGFR3—germ cell cancer	0.000186	0.00271	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—FGFR3—germ cell cancer	0.000185	0.0027	CbGpPWpGaD
Mesalazine—Myalgia—Cisplatin—germ cell cancer	0.000185	0.000701	CcSEcCtD
Mesalazine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000185	0.000701	CcSEcCtD
Mesalazine—Paraesthesia—Ifosfamide—germ cell cancer	0.000185	0.0007	CcSEcCtD
Mesalazine—Ill-defined disorder—Etoposide—germ cell cancer	0.000185	0.0007	CcSEcCtD
Mesalazine—CHUK—Signaling by ERBB2—FGFR3—germ cell cancer	0.000185	0.00268	CbGpPWpGaD
Mesalazine—Anxiety—Cisplatin—germ cell cancer	0.000184	0.000698	CcSEcCtD
Mesalazine—Anaemia—Etoposide—germ cell cancer	0.000184	0.000697	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000184	0.000696	CcSEcCtD
Mesalazine—CHUK—DAP12 signaling—FGFR3—germ cell cancer	0.000184	0.00267	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000184	0.000695	CcSEcCtD
Mesalazine—Dyspnoea—Ifosfamide—germ cell cancer	0.000183	0.000695	CcSEcCtD
Mesalazine—Somnolence—Ifosfamide—germ cell cancer	0.000183	0.000693	CcSEcCtD
Mesalazine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000183	0.000693	CcSEcCtD
Mesalazine—Discomfort—Cisplatin—germ cell cancer	0.000183	0.000692	CcSEcCtD
Mesalazine—CHUK—Downstream signaling of activated FGFR—KIT—germ cell cancer	0.000182	0.00265	CbGpPWpGaD
Mesalazine—Vomiting—Vinblastine—germ cell cancer	0.000181	0.000686	CcSEcCtD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—germ cell cancer	0.000181	0.00263	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—SOX2—germ cell cancer	0.000181	0.00263	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—HRAS—germ cell cancer	0.00018	0.00262	CbGpPWpGaD
Mesalazine—Malaise—Etoposide—germ cell cancer	0.00018	0.00068	CcSEcCtD
Mesalazine—CHUK—Signaling by ERBB4—KIT—germ cell cancer	0.000179	0.00261	CbGpPWpGaD
Mesalazine—Breast disorder—Methotrexate—germ cell cancer	0.000179	0.000678	CcSEcCtD
Mesalazine—Vertigo—Etoposide—germ cell cancer	0.000179	0.000678	CcSEcCtD
Mesalazine—Decreased appetite—Ifosfamide—germ cell cancer	0.000179	0.000677	CcSEcCtD
Mesalazine—Headache—Vinblastine—germ cell cancer	0.000179	0.000676	CcSEcCtD
Mesalazine—Leukopenia—Etoposide—germ cell cancer	0.000178	0.000675	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000178	0.000673	CcSEcCtD
Mesalazine—Body temperature increased—Dactinomycin—germ cell cancer	0.000177	0.000672	CcSEcCtD
Mesalazine—Abdominal pain—Dactinomycin—germ cell cancer	0.000177	0.000672	CcSEcCtD
Mesalazine—Fatigue—Ifosfamide—germ cell cancer	0.000177	0.000672	CcSEcCtD
Mesalazine—Oedema—Cisplatin—germ cell cancer	0.000177	0.000672	CcSEcCtD
Mesalazine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000177	0.000672	CcSEcCtD
Mesalazine—Hypersensitivity—Bleomycin—germ cell cancer	0.000177	0.000672	CcSEcCtD
Mesalazine—Infection—Cisplatin—germ cell cancer	0.000176	0.000667	CcSEcCtD
Mesalazine—Pain—Ifosfamide—germ cell cancer	0.000176	0.000666	CcSEcCtD
Mesalazine—Constipation—Ifosfamide—germ cell cancer	0.000176	0.000666	CcSEcCtD
Mesalazine—Loss of consciousness—Etoposide—germ cell cancer	0.000175	0.000663	CcSEcCtD
Mesalazine—IKBKB—Signaling by NGF—FGF4—germ cell cancer	0.000175	0.00254	CbGpPWpGaD
Mesalazine—Nervous system disorder—Cisplatin—germ cell cancer	0.000174	0.000659	CcSEcCtD
Mesalazine—Cough—Etoposide—germ cell cancer	0.000174	0.000658	CcSEcCtD
Mesalazine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000174	0.000658	CcSEcCtD
Mesalazine—Tachycardia—Cisplatin—germ cell cancer	0.000173	0.000656	CcSEcCtD
Mesalazine—PPARG—Gene Expression—DNMT3L—germ cell cancer	0.000173	0.00252	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000173	0.00251	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000173	0.00251	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—FGFR3—germ cell cancer	0.000173	0.00251	CbGpPWpGaD
Mesalazine—Asthenia—Bleomycin—germ cell cancer	0.000173	0.000654	CcSEcCtD
Mesalazine—Skin disorder—Cisplatin—germ cell cancer	0.000172	0.000653	CcSEcCtD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	0.000172	0.0025	CbGpPWpGaD
Mesalazine—Hypertension—Etoposide—germ cell cancer	0.000172	0.000651	CcSEcCtD
Mesalazine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000171	0.000649	CcSEcCtD
Mesalazine—CHUK—Signaling by EGFR—FGFR3—germ cell cancer	0.000171	0.00249	CbGpPWpGaD
Mesalazine—Asthma—Methotrexate—germ cell cancer	0.000171	0.000648	CcSEcCtD
Mesalazine—CHUK—Downstream signal transduction—KIT—germ cell cancer	0.000171	0.00249	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—KIT—germ cell cancer	0.000171	0.00248	CbGpPWpGaD
Mesalazine—Pruritus—Bleomycin—germ cell cancer	0.00017	0.000645	CcSEcCtD
Mesalazine—CHUK—Signaling by FGFR—KIT—germ cell cancer	0.00017	0.00248	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.00017	0.00247	CbGpPWpGaD
Mesalazine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00017	0.000642	CcSEcCtD
Mesalazine—Chest pain—Etoposide—germ cell cancer	0.000169	0.000642	CcSEcCtD
Mesalazine—Eosinophilia—Methotrexate—germ cell cancer	0.000169	0.000642	CcSEcCtD
Mesalazine—CHUK—Signaling by ERBB2—KIT—germ cell cancer	0.000169	0.00246	CbGpPWpGaD
Mesalazine—Nausea—Vinblastine—germ cell cancer	0.000169	0.000641	CcSEcCtD
Mesalazine—Anorexia—Cisplatin—germ cell cancer	0.000169	0.00064	CcSEcCtD
Mesalazine—CHUK—Signaling by PDGF—FGFR3—germ cell cancer	0.000169	0.00246	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—KIT—germ cell cancer	0.000169	0.00245	CbGpPWpGaD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000168	0.000638	CcSEcCtD
Mesalazine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000168	0.000637	CcSEcCtD
Mesalazine—Pancreatitis—Methotrexate—germ cell cancer	0.000168	0.000636	CcSEcCtD
Mesalazine—Discomfort—Etoposide—germ cell cancer	0.000167	0.000634	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—PVRL2—germ cell cancer	0.000167	0.00243	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	0.000166	0.00242	CbGpPWpGaD
Mesalazine—Hypotension—Cisplatin—germ cell cancer	0.000166	0.000628	CcSEcCtD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000166	0.00241	CbGpPWpGaD
Mesalazine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000165	0.000627	CcSEcCtD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—germ cell cancer	0.000164	0.00239	CbGpPWpGaD
Mesalazine—Abdominal discomfort—Methotrexate—germ cell cancer	0.000164	0.000622	CcSEcCtD
Mesalazine—Confusional state—Etoposide—germ cell cancer	0.000164	0.000621	CcSEcCtD
Mesalazine—Urticaria—Ifosfamide—germ cell cancer	0.000163	0.000619	CcSEcCtD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—germ cell cancer	0.000163	0.00237	CbGpPWpGaD
Mesalazine—Abdominal pain—Ifosfamide—germ cell cancer	0.000163	0.000616	CcSEcCtD
Mesalazine—Body temperature increased—Ifosfamide—germ cell cancer	0.000163	0.000616	CcSEcCtD
Mesalazine—Pancytopenia—Methotrexate—germ cell cancer	0.000163	0.000616	CcSEcCtD
Mesalazine—Anaphylactic shock—Etoposide—germ cell cancer	0.000162	0.000615	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000162	0.000612	CcSEcCtD
Mesalazine—Infection—Etoposide—germ cell cancer	0.000161	0.000611	CcSEcCtD
Mesalazine—Asthenia—Dactinomycin—germ cell cancer	0.000161	0.00061	CcSEcCtD
Mesalazine—PPARG—Gene Expression—RARS—germ cell cancer	0.000161	0.00234	CbGpPWpGaD
Mesalazine—CHUK—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	0.000161	0.00234	CbGpPWpGaD
Mesalazine—Dysuria—Methotrexate—germ cell cancer	0.00016	0.000606	CcSEcCtD
Mesalazine—Neutropenia—Methotrexate—germ cell cancer	0.00016	0.000606	CcSEcCtD
Mesalazine—CHUK—B Cell Activation—FGFR3—germ cell cancer	0.00016	0.00233	CbGpPWpGaD
Mesalazine—Paraesthesia—Cisplatin—germ cell cancer	0.000159	0.000603	CcSEcCtD
Mesalazine—Thrombocytopenia—Etoposide—germ cell cancer	0.000159	0.000603	CcSEcCtD
Mesalazine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000159	0.000603	CcSEcCtD
Mesalazine—CHUK—DAP12 interactions—KIT—germ cell cancer	0.000159	0.00231	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—KIT—germ cell cancer	0.000159	0.00231	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000159	0.00231	CbGpPWpGaD
Mesalazine—Tachycardia—Etoposide—germ cell cancer	0.000159	0.000601	CcSEcCtD
Mesalazine—CHUK—Apoptosis—MYC—germ cell cancer	0.000158	0.0023	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—KITLG—germ cell cancer	0.000158	0.0023	CbGpPWpGaD
Mesalazine—Dyspnoea—Cisplatin—germ cell cancer	0.000158	0.000599	CcSEcCtD
Mesalazine—Skin disorder—Etoposide—germ cell cancer	0.000158	0.000598	CcSEcCtD
Mesalazine—CHUK—Signaling by EGFR—KIT—germ cell cancer	0.000157	0.00229	CbGpPWpGaD
Mesalazine—Hyperhidrosis—Etoposide—germ cell cancer	0.000157	0.000595	CcSEcCtD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000157	0.00228	CbGpPWpGaD
Mesalazine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000156	0.000592	CcSEcCtD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	0.000156	0.00227	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.000156	0.00227	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000155	0.00226	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—KIT—germ cell cancer	0.000155	0.00226	CbGpPWpGaD
Mesalazine—Anorexia—Etoposide—germ cell cancer	0.000155	0.000587	CcSEcCtD
Mesalazine—Decreased appetite—Cisplatin—germ cell cancer	0.000154	0.000584	CcSEcCtD
Mesalazine—Diarrhoea—Dactinomycin—germ cell cancer	0.000154	0.000582	CcSEcCtD
Mesalazine—Pneumonia—Methotrexate—germ cell cancer	0.000153	0.000581	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000153	0.00058	CcSEcCtD
Mesalazine—Vomiting—Bleomycin—germ cell cancer	0.000153	0.00058	CcSEcCtD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000153	0.00223	CbGpPWpGaD
Mesalazine—Infestation—Methotrexate—germ cell cancer	0.000153	0.000578	CcSEcCtD
Mesalazine—Infestation NOS—Methotrexate—germ cell cancer	0.000153	0.000578	CcSEcCtD
Mesalazine—CHUK—p75(NTR)-mediated signaling—TP53—germ cell cancer	0.000152	0.00222	CbGpPWpGaD
Mesalazine—Depression—Methotrexate—germ cell cancer	0.000152	0.000576	CcSEcCtD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000152	0.00221	CbGpPWpGaD
Mesalazine—Hypotension—Etoposide—germ cell cancer	0.000152	0.000575	CcSEcCtD
Mesalazine—Rash—Bleomycin—germ cell cancer	0.000152	0.000575	CcSEcCtD
Mesalazine—Pain—Cisplatin—germ cell cancer	0.000152	0.000575	CcSEcCtD
Mesalazine—Dermatitis—Bleomycin—germ cell cancer	0.000152	0.000574	CcSEcCtD
Mesalazine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000152	0.000574	CcSEcCtD
Mesalazine—IKBKB—Adaptive Immune System—PVRL2—germ cell cancer	0.000152	0.0022	CbGpPWpGaD
Mesalazine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000151	0.000573	CcSEcCtD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—HRAS—germ cell cancer	0.000151	0.0022	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	0.000151	0.00219	CbGpPWpGaD
Mesalazine—Renal failure—Methotrexate—germ cell cancer	0.00015	0.000568	CcSEcCtD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	0.000149	0.00217	CbGpPWpGaD
Mesalazine—CHUK—BCR signaling pathway—HRAS—germ cell cancer	0.000149	0.00217	CbGpPWpGaD
Mesalazine—Stomatitis—Methotrexate—germ cell cancer	0.000149	0.000563	CcSEcCtD
Mesalazine—ALOX5—Metabolism—SLC2A3—germ cell cancer	0.000148	0.00216	CbGpPWpGaD
Mesalazine—Conjunctivitis—Methotrexate—germ cell cancer	0.000148	0.000562	CcSEcCtD
Mesalazine—Asthenia—Ifosfamide—germ cell cancer	0.000148	0.000559	CcSEcCtD
Mesalazine—CHUK—B Cell Activation—KIT—germ cell cancer	0.000147	0.00214	CbGpPWpGaD
Mesalazine—Sweating—Methotrexate—germ cell cancer	0.000146	0.000554	CcSEcCtD
Mesalazine—Feeling abnormal—Cisplatin—germ cell cancer	0.000146	0.000554	CcSEcCtD
Mesalazine—ALOX5—Metabolism—SLC22A3—germ cell cancer	0.000146	0.00213	CbGpPWpGaD
Mesalazine—Paraesthesia—Etoposide—germ cell cancer	0.000146	0.000553	CcSEcCtD
Mesalazine—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	0.000146	0.00212	CbGpPWpGaD
Mesalazine—Pruritus—Ifosfamide—germ cell cancer	0.000146	0.000551	CcSEcCtD
Mesalazine—Haematuria—Methotrexate—germ cell cancer	0.000145	0.000551	CcSEcCtD
Mesalazine—IKBKB—B Cell Activation—FGFR3—germ cell cancer	0.000145	0.00211	CbGpPWpGaD
Mesalazine—Dyspnoea—Etoposide—germ cell cancer	0.000145	0.000549	CcSEcCtD
Mesalazine—Somnolence—Etoposide—germ cell cancer	0.000144	0.000547	CcSEcCtD
Mesalazine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000144	0.000547	CcSEcCtD
Mesalazine—Epistaxis—Methotrexate—germ cell cancer	0.000144	0.000545	CcSEcCtD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000144	0.00209	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—MYC—germ cell cancer	0.000144	0.00209	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—KITLG—germ cell cancer	0.000144	0.00209	CbGpPWpGaD
Mesalazine—Nausea—Bleomycin—germ cell cancer	0.000143	0.000542	CcSEcCtD
Mesalazine—Vomiting—Dactinomycin—germ cell cancer	0.000143	0.000541	CcSEcCtD
Mesalazine—Agranulocytosis—Methotrexate—germ cell cancer	0.000142	0.000539	CcSEcCtD
Mesalazine—Rash—Dactinomycin—germ cell cancer	0.000142	0.000536	CcSEcCtD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	0.000141	0.00206	CbGpPWpGaD
Mesalazine—Decreased appetite—Etoposide—germ cell cancer	0.000141	0.000535	CcSEcCtD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	0.000141	0.00205	CbGpPWpGaD
Mesalazine—Diarrhoea—Ifosfamide—germ cell cancer	0.000141	0.000533	CcSEcCtD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.00014	0.00204	CbGpPWpGaD
Mesalazine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00014	0.000531	CcSEcCtD
Mesalazine—Body temperature increased—Cisplatin—germ cell cancer	0.00014	0.000531	CcSEcCtD
Mesalazine—Fatigue—Etoposide—germ cell cancer	0.00014	0.000531	CcSEcCtD
Mesalazine—Constipation—Etoposide—germ cell cancer	0.000139	0.000526	CcSEcCtD
Mesalazine—Pain—Etoposide—germ cell cancer	0.000139	0.000526	CcSEcCtD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—TP53—germ cell cancer	0.000138	0.00201	CbGpPWpGaD
Mesalazine—Haemoglobin—Methotrexate—germ cell cancer	0.000138	0.000522	CcSEcCtD
Mesalazine—Haemorrhage—Methotrexate—germ cell cancer	0.000137	0.000519	CcSEcCtD
Mesalazine—Hepatitis—Methotrexate—germ cell cancer	0.000137	0.000519	CcSEcCtD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—germ cell cancer	0.000137	0.00199	CbGpPWpGaD
Mesalazine—IKBKB—mTOR signaling pathway—HRAS—germ cell cancer	0.000137	0.00199	CbGpPWpGaD
Mesalazine—CHUK—Leptin signaling pathway—HRAS—germ cell cancer	0.000136	0.00198	CbGpPWpGaD
Mesalazine—Dizziness—Ifosfamide—germ cell cancer	0.000136	0.000515	CcSEcCtD
Mesalazine—Pharyngitis—Methotrexate—germ cell cancer	0.000136	0.000515	CcSEcCtD
Mesalazine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000135	0.000512	CcSEcCtD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	0.000135	0.00197	CbGpPWpGaD
Mesalazine—IKBKB—BCR signaling pathway—HRAS—germ cell cancer	0.000135	0.00197	CbGpPWpGaD
Mesalazine—Urethral disorder—Methotrexate—germ cell cancer	0.000134	0.000509	CcSEcCtD
Mesalazine—Feeling abnormal—Etoposide—germ cell cancer	0.000134	0.000507	CcSEcCtD
Mesalazine—Nausea—Dactinomycin—germ cell cancer	0.000133	0.000505	CcSEcCtD
Mesalazine—IKBKB—B Cell Activation—KIT—germ cell cancer	0.000133	0.00194	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000133	0.000503	CcSEcCtD
Mesalazine—Vomiting—Ifosfamide—germ cell cancer	0.000131	0.000495	CcSEcCtD
Mesalazine—Hypersensitivity—Cisplatin—germ cell cancer	0.000131	0.000495	CcSEcCtD
Mesalazine—CHUK—Apoptosis—TP53—germ cell cancer	0.00013	0.00189	CbGpPWpGaD
Mesalazine—Rash—Ifosfamide—germ cell cancer	0.00013	0.000491	CcSEcCtD
Mesalazine—Dermatitis—Ifosfamide—germ cell cancer	0.00013	0.000491	CcSEcCtD
Mesalazine—Erythema multiforme—Methotrexate—germ cell cancer	0.00013	0.000491	CcSEcCtD
Mesalazine—Urticaria—Etoposide—germ cell cancer	0.000129	0.000489	CcSEcCtD
Mesalazine—Body temperature increased—Etoposide—germ cell cancer	0.000128	0.000487	CcSEcCtD
Mesalazine—Abdominal pain—Etoposide—germ cell cancer	0.000128	0.000487	CcSEcCtD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	0.000128	0.00186	CbGpPWpGaD
Mesalazine—Eye disorder—Methotrexate—germ cell cancer	0.000128	0.000485	CcSEcCtD
Mesalazine—Tinnitus—Methotrexate—germ cell cancer	0.000128	0.000484	CcSEcCtD
Mesalazine—Asthenia—Cisplatin—germ cell cancer	0.000127	0.000482	CcSEcCtD
Mesalazine—Cardiac disorder—Methotrexate—germ cell cancer	0.000127	0.000482	CcSEcCtD
Mesalazine—Angiopathy—Methotrexate—germ cell cancer	0.000124	0.000471	CcSEcCtD
Mesalazine—Immune system disorder—Methotrexate—germ cell cancer	0.000124	0.000469	CcSEcCtD
Mesalazine—IKBKB—Leptin signaling pathway—HRAS—germ cell cancer	0.000124	0.0018	CbGpPWpGaD
Mesalazine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000123	0.000468	CcSEcCtD
Mesalazine—Chills—Methotrexate—germ cell cancer	0.000123	0.000466	CcSEcCtD
Mesalazine—Nausea—Ifosfamide—germ cell cancer	0.000122	0.000463	CcSEcCtD
Mesalazine—Diarrhoea—Cisplatin—germ cell cancer	0.000121	0.00046	CcSEcCtD
Mesalazine—Alopecia—Methotrexate—germ cell cancer	0.000121	0.000459	CcSEcCtD
Mesalazine—Mental disorder—Methotrexate—germ cell cancer	0.00012	0.000455	CcSEcCtD
Mesalazine—Hypersensitivity—Etoposide—germ cell cancer	0.00012	0.000453	CcSEcCtD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000119	0.00174	CbGpPWpGaD
Mesalazine—Erythema—Methotrexate—germ cell cancer	0.000119	0.000452	CcSEcCtD
Mesalazine—ALOX5—Metabolism—CRABP1—germ cell cancer	0.000119	0.00173	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TP53—germ cell cancer	0.000118	0.00172	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—HRAS—germ cell cancer	0.000118	0.00171	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—FGFR3—germ cell cancer	0.000118	0.00171	CbGpPWpGaD
Mesalazine—Dysgeusia—Methotrexate—germ cell cancer	0.000117	0.000442	CcSEcCtD
Mesalazine—Asthenia—Etoposide—germ cell cancer	0.000117	0.000442	CcSEcCtD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000116	0.00169	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—HRAS—germ cell cancer	0.000116	0.00168	CbGpPWpGaD
Mesalazine—Back pain—Methotrexate—germ cell cancer	0.000115	0.000437	CcSEcCtD
Mesalazine—Pruritus—Etoposide—germ cell cancer	0.000115	0.000435	CcSEcCtD
Mesalazine—Vomiting—Cisplatin—germ cell cancer	0.000113	0.000427	CcSEcCtD
Mesalazine—Vision blurred—Methotrexate—germ cell cancer	0.000112	0.000426	CcSEcCtD
Mesalazine—Rash—Cisplatin—germ cell cancer	0.000112	0.000424	CcSEcCtD
Mesalazine—Dermatitis—Cisplatin—germ cell cancer	0.000112	0.000423	CcSEcCtD
Mesalazine—Diarrhoea—Etoposide—germ cell cancer	0.000111	0.000421	CcSEcCtD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.000111	0.00161	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—germ cell cancer	0.000111	0.00161	CbGpPWpGaD
Mesalazine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000111	0.000419	CcSEcCtD
Mesalazine—Anaemia—Methotrexate—germ cell cancer	0.00011	0.000418	CcSEcCtD
Mesalazine—CHUK—Innate Immune System—FGF4—germ cell cancer	0.00011	0.0016	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—KIT—germ cell cancer	0.000108	0.00157	CbGpPWpGaD
Mesalazine—Malaise—Methotrexate—germ cell cancer	0.000108	0.000407	CcSEcCtD
Mesalazine—Dizziness—Etoposide—germ cell cancer	0.000107	0.000407	CcSEcCtD
Mesalazine—Vertigo—Methotrexate—germ cell cancer	0.000107	0.000406	CcSEcCtD
Mesalazine—IKBKB—TCR Signaling Pathway—HRAS—germ cell cancer	0.000107	0.00155	CbGpPWpGaD
Mesalazine—Leukopenia—Methotrexate—germ cell cancer	0.000107	0.000404	CcSEcCtD
Mesalazine—IKBKB—Signaling by NGF—FGFR3—germ cell cancer	0.000107	0.00155	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—FGF4—germ cell cancer	0.000106	0.00154	CbGpPWpGaD
Mesalazine—Nausea—Cisplatin—germ cell cancer	0.000105	0.000399	CcSEcCtD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—HRAS—germ cell cancer	0.000105	0.00153	CbGpPWpGaD
Mesalazine—Cough—Methotrexate—germ cell cancer	0.000104	0.000394	CcSEcCtD
Mesalazine—Vomiting—Etoposide—germ cell cancer	0.000103	0.000391	CcSEcCtD
Mesalazine—CHUK—Disease—SLC2A3—germ cell cancer	0.000103	0.0015	CbGpPWpGaD
Mesalazine—Rash—Etoposide—germ cell cancer	0.000102	0.000388	CcSEcCtD
Mesalazine—Dermatitis—Etoposide—germ cell cancer	0.000102	0.000388	CcSEcCtD
Mesalazine—Headache—Etoposide—germ cell cancer	0.000102	0.000386	CcSEcCtD
Mesalazine—CHUK—Signaling by Interleukins—HRAS—germ cell cancer	0.000102	0.00148	CbGpPWpGaD
Mesalazine—Chest pain—Methotrexate—germ cell cancer	0.000102	0.000385	CcSEcCtD
Mesalazine—Arthralgia—Methotrexate—germ cell cancer	0.000102	0.000385	CcSEcCtD
Mesalazine—Myalgia—Methotrexate—germ cell cancer	0.000102	0.000385	CcSEcCtD
Mesalazine—CHUK—Immune System—PVRL2—germ cell cancer	0.000101	0.00147	CbGpPWpGaD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000101	0.000382	CcSEcCtD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.000101	0.00146	CbGpPWpGaD
Mesalazine—Discomfort—Methotrexate—germ cell cancer	0.0001	0.00038	CcSEcCtD
Mesalazine—IKBKB—Innate Immune System—FGF4—germ cell cancer	9.97e-05	0.00145	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—MYC—germ cell cancer	9.91e-05	0.00144	CbGpPWpGaD
Mesalazine—Confusional state—Methotrexate—germ cell cancer	9.81e-05	0.000372	CcSEcCtD
Mesalazine—IKBKB—Signaling by NGF—KIT—germ cell cancer	9.8e-05	0.00143	CbGpPWpGaD
Mesalazine—Anaphylactic shock—Methotrexate—germ cell cancer	9.73e-05	0.000369	CcSEcCtD
Mesalazine—Infection—Methotrexate—germ cell cancer	9.67e-05	0.000366	CcSEcCtD
Mesalazine—Nausea—Etoposide—germ cell cancer	9.65e-05	0.000366	CcSEcCtD
Mesalazine—IKBKB—Adaptive Immune System—FGF4—germ cell cancer	9.57e-05	0.00139	CbGpPWpGaD
Mesalazine—Nervous system disorder—Methotrexate—germ cell cancer	9.54e-05	0.000362	CcSEcCtD
Mesalazine—Thrombocytopenia—Methotrexate—germ cell cancer	9.53e-05	0.000361	CcSEcCtD
Mesalazine—Skin disorder—Methotrexate—germ cell cancer	9.45e-05	0.000358	CcSEcCtD
Mesalazine—Hyperhidrosis—Methotrexate—germ cell cancer	9.41e-05	0.000356	CcSEcCtD
Mesalazine—PTGS2—C-MYB transcription factor network—MYC—germ cell cancer	9.39e-05	0.00137	CbGpPWpGaD
Mesalazine—Anorexia—Methotrexate—germ cell cancer	9.28e-05	0.000351	CcSEcCtD
Mesalazine—IKBKB—Signaling by Interleukins—HRAS—germ cell cancer	9.23e-05	0.00134	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.21e-05	0.00134	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PVRL2—germ cell cancer	9.19e-05	0.00134	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—SLC2A3—germ cell cancer	9.18e-05	0.00134	CbGpPWpGaD
Mesalazine—Hypotension—Methotrexate—germ cell cancer	9.09e-05	0.000344	CcSEcCtD
Mesalazine—PPARG—Metabolism—SLC22A3—germ cell cancer	9.05e-05	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—KITLG—germ cell cancer	9.03e-05	0.00131	CbGpPWpGaD
Mesalazine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	8.87e-05	0.000336	CcSEcCtD
Mesalazine—Insomnia—Methotrexate—germ cell cancer	8.8e-05	0.000333	CcSEcCtD
Mesalazine—Paraesthesia—Methotrexate—germ cell cancer	8.74e-05	0.000331	CcSEcCtD
Mesalazine—Dyspnoea—Methotrexate—germ cell cancer	8.68e-05	0.000329	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—KITLG—germ cell cancer	8.67e-05	0.00126	CbGpPWpGaD
Mesalazine—Somnolence—Methotrexate—germ cell cancer	8.65e-05	0.000328	CcSEcCtD
Mesalazine—Dyspepsia—Methotrexate—germ cell cancer	8.57e-05	0.000325	CcSEcCtD
Mesalazine—Decreased appetite—Methotrexate—germ cell cancer	8.46e-05	0.00032	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Methotrexate—germ cell cancer	8.4e-05	0.000318	CcSEcCtD
Mesalazine—Fatigue—Methotrexate—germ cell cancer	8.39e-05	0.000318	CcSEcCtD
Mesalazine—Pain—Methotrexate—germ cell cancer	8.32e-05	0.000315	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—MYC—germ cell cancer	8.25e-05	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—HRAS—germ cell cancer	8.22e-05	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	8.21e-05	0.00119	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—KITLG—germ cell cancer	8.19e-05	0.00119	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—germ cell cancer	8.14e-05	0.00118	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—HRAS—germ cell cancer	8.09e-05	0.00118	CbGpPWpGaD
Mesalazine—Feeling abnormal—Methotrexate—germ cell cancer	8.02e-05	0.000304	CcSEcCtD
Mesalazine—Gastrointestinal pain—Methotrexate—germ cell cancer	7.96e-05	0.000301	CcSEcCtD
Mesalazine—CHUK—Downstream signaling of activated FGFR—HRAS—germ cell cancer	7.87e-05	0.00114	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—KITLG—germ cell cancer	7.86e-05	0.00114	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—HRAS—germ cell cancer	7.74e-05	0.00113	CbGpPWpGaD
Mesalazine—Urticaria—Methotrexate—germ cell cancer	7.73e-05	0.000293	CcSEcCtD
Mesalazine—Abdominal pain—Methotrexate—germ cell cancer	7.69e-05	0.000291	CcSEcCtD
Mesalazine—Body temperature increased—Methotrexate—germ cell cancer	7.69e-05	0.000291	CcSEcCtD
Mesalazine—CHUK—Downstream signal transduction—HRAS—germ cell cancer	7.39e-05	0.00108	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CRABP1—germ cell cancer	7.37e-05	0.00107	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—HRAS—germ cell cancer	7.37e-05	0.00107	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—HRAS—germ cell cancer	7.36e-05	0.00107	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—HRAS—germ cell cancer	7.33e-05	0.00107	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—HRAS—germ cell cancer	7.32e-05	0.00107	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—HRAS—germ cell cancer	7.29e-05	0.00106	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	7.18e-05	0.00104	CbGpPWpGaD
Mesalazine—Hypersensitivity—Methotrexate—germ cell cancer	7.17e-05	0.000272	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—MYC—germ cell cancer	7.15e-05	0.00104	CbGpPWpGaD
Mesalazine—Asthenia—Methotrexate—germ cell cancer	6.98e-05	0.000265	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—TP53—germ cell cancer	6.9e-05	0.001	CbGpPWpGaD
Mesalazine—Pruritus—Methotrexate—germ cell cancer	6.89e-05	0.000261	CcSEcCtD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	6.86e-05	0.000997	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—HRAS—germ cell cancer	6.86e-05	0.000997	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—HRAS—germ cell cancer	6.86e-05	0.000997	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—HRAS—germ cell cancer	6.79e-05	0.000988	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—germ cell cancer	6.78e-05	0.000986	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	6.74e-05	0.000981	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—HRAS—germ cell cancer	6.74e-05	0.00098	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—HRAS—germ cell cancer	6.73e-05	0.00098	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—FGFR3—germ cell cancer	6.71e-05	0.000977	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—HRAS—germ cell cancer	6.7e-05	0.000975	CbGpPWpGaD
Mesalazine—Diarrhoea—Methotrexate—germ cell cancer	6.66e-05	0.000252	CcSEcCtD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	6.51e-05	0.000947	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—FGFR3—germ cell cancer	6.45e-05	0.000938	CbGpPWpGaD
Mesalazine—Dizziness—Methotrexate—germ cell cancer	6.44e-05	0.000244	CcSEcCtD
Mesalazine—PTGS1—Metabolism—SLC2A3—germ cell cancer	6.43e-05	0.000936	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FGF4—germ cell cancer	6.4e-05	0.000932	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—HRAS—germ cell cancer	6.34e-05	0.000923	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—SLC22A3—germ cell cancer	6.34e-05	0.000922	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	6.22e-05	0.000904	CbGpPWpGaD
Mesalazine—Vomiting—Methotrexate—germ cell cancer	6.19e-05	0.000234	CcSEcCtD
Mesalazine—CHUK—Innate Immune System—KIT—germ cell cancer	6.16e-05	0.000897	CbGpPWpGaD
Mesalazine—Rash—Methotrexate—germ cell cancer	6.14e-05	0.000232	CcSEcCtD
Mesalazine—Dermatitis—Methotrexate—germ cell cancer	6.13e-05	0.000232	CcSEcCtD
Mesalazine—PTGS2—Disease—SLC2A3—germ cell cancer	6.1e-05	0.000887	CbGpPWpGaD
Mesalazine—Headache—Methotrexate—germ cell cancer	6.1e-05	0.000231	CcSEcCtD
Mesalazine—IKBKB—Innate Immune System—FGFR3—germ cell cancer	6.09e-05	0.000885	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	6.07e-05	0.000883	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—H2AFZ—germ cell cancer	6.06e-05	0.000881	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—KIT—germ cell cancer	5.92e-05	0.000861	CbGpPWpGaD
Mesalazine—CHUK—Disease—FGF4—germ cell cancer	5.91e-05	0.00086	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—germ cell cancer	5.87e-05	0.000854	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—FGFR3—germ cell cancer	5.85e-05	0.00085	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FGF4—germ cell cancer	5.81e-05	0.000845	CbGpPWpGaD
Mesalazine—Nausea—Methotrexate—germ cell cancer	5.78e-05	0.000219	CcSEcCtD
Mesalazine—IKBKB—B Cell Activation—HRAS—germ cell cancer	5.75e-05	0.000837	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—KIT—germ cell cancer	5.59e-05	0.000813	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—KIT—germ cell cancer	5.37e-05	0.000781	CbGpPWpGaD
Mesalazine—CHUK—Disease—H2AFZ—germ cell cancer	5.28e-05	0.000768	CbGpPWpGaD
Mesalazine—CHUK—Immune System—KITLG—germ cell cancer	5.26e-05	0.000765	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CRABP1—germ cell cancer	5.17e-05	0.000751	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SLC2A3—germ cell cancer	5.11e-05	0.000743	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SLC22A3—germ cell cancer	5.03e-05	0.000732	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.86e-05	0.000708	CbGpPWpGaD
Mesalazine—CHUK—Disease—KITLG—germ cell cancer	4.86e-05	0.000707	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—OXT—germ cell cancer	4.85e-05	0.000706	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—KITLG—germ cell cancer	4.77e-05	0.000694	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HRAS—germ cell cancer	4.75e-05	0.000691	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—HRAS—germ cell cancer	4.67e-05	0.000679	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—OXT—germ cell cancer	4.4e-05	0.00064	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—MYC—germ cell cancer	4.35e-05	0.000632	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—germ cell cancer	4.31e-05	0.000627	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—HRAS—germ cell cancer	4.23e-05	0.000616	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGF4—germ cell cancer	4.14e-05	0.000602	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CRABP1—germ cell cancer	4.1e-05	0.000596	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4e-05	0.000581	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FGFR3—germ cell cancer	3.91e-05	0.000569	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGF4—germ cell cancer	3.75e-05	0.000546	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—H2AFZ—germ cell cancer	3.7e-05	0.000538	CbGpPWpGaD
Mesalazine—CHUK—Disease—FGFR3—germ cell cancer	3.61e-05	0.000525	CbGpPWpGaD
Mesalazine—CHUK—Immune System—KIT—germ cell cancer	3.59e-05	0.000522	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FGFR3—germ cell cancer	3.55e-05	0.000516	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGF4—germ cell cancer	3.5e-05	0.000509	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KITLG—germ cell cancer	3.4e-05	0.000495	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—H2AFZ—germ cell cancer	3.35e-05	0.000488	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AVP—germ cell cancer	3.32e-05	0.000484	CbGpPWpGaD
Mesalazine—CHUK—Disease—KIT—germ cell cancer	3.31e-05	0.000482	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—KIT—germ cell cancer	3.26e-05	0.000474	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—HRAS—germ cell cancer	3.21e-05	0.000467	CbGpPWpGaD
Mesalazine—PTGS2—Disease—H2AFZ—germ cell cancer	3.13e-05	0.000455	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KITLG—germ cell cancer	3.08e-05	0.000449	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AVP—germ cell cancer	3.01e-05	0.000439	CbGpPWpGaD
Mesalazine—PTGS2—Disease—KITLG—germ cell cancer	2.88e-05	0.000419	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—HRAS—germ cell cancer	2.66e-05	0.000387	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HRAS—germ cell cancer	2.56e-05	0.000372	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGFR3—germ cell cancer	2.53e-05	0.000368	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—HRAS—germ cell cancer	2.42e-05	0.000351	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KIT—germ cell cancer	2.32e-05	0.000338	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HRAS—germ cell cancer	2.32e-05	0.000337	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGFR3—germ cell cancer	2.29e-05	0.000333	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGFR3—germ cell cancer	2.14e-05	0.000311	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KIT—germ cell cancer	2.1e-05	0.000306	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MYC—germ cell cancer	2.09e-05	0.000304	CbGpPWpGaD
Mesalazine—PTGS2—Disease—KIT—germ cell cancer	1.96e-05	0.000286	CbGpPWpGaD
Mesalazine—CHUK—Disease—MYC—germ cell cancer	1.82e-05	0.000265	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HRAS—germ cell cancer	1.55e-05	0.000226	CbGpPWpGaD
Mesalazine—CHUK—Disease—HRAS—germ cell cancer	1.43e-05	0.000208	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HRAS—germ cell cancer	1.41e-05	0.000205	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MYC—germ cell cancer	1.28e-05	0.000186	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MYC—germ cell cancer	1.16e-05	0.000168	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MYC—germ cell cancer	1.08e-05	0.000157	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—germ cell cancer	1.05e-05	0.000153	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HRAS—germ cell cancer	1e-05	0.000146	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—germ cell cancer	9.51e-06	0.000138	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HRAS—germ cell cancer	9.09e-06	0.000132	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HRAS—germ cell cancer	8.48e-06	0.000123	CbGpPWpGaD
